Patients as Partners® Europe Announces the Launch of 8th Annual Meeting with 2024 Keynotes and Topics

(IN BRIEF) The Conference Forum announced the launch of the 8th annual Patients as Partners® Europe meeting, scheduled for May 14-15, 2024, at Plaisterers’ Hall in London, England. This event brings together pharma R&D and patient advocacy to discuss patient involvement in clinical research, aiming to enhance efficiency and inclusivity with better outcomes. Keynote speakers include patient advocates, industry leaders from GSK, Pfizer, Lundbeck, Boehringer Ingelheim, Ipsen, AstraZeneca, Astellas, and Prostate Cancer Research. The meeting will cover various topics such as patient-informed research, decentralized clinical trials, health equity, patient experience data, patient engagement, and regulatory requirements. Co-chaired by representatives from Sanofi, patient advocacy, and Parexel, the event aims to advance patient involvement, access, and diversity in clinical development. For more information and the full agenda, visit PatientsAsPartnersEU.com.

(PRESS RELEASE) NEW YORK, NY, United States, 12-Mar-2024 — /EuropaWire/ — The Conference Forum today announced the launch of the 8th annual Patients as Partners® Europe meeting, taking place May 14-15, 2024, at Plaisterers’ Hall, in London, England. Patients as Partners® Europe offers an unparalleled opportunity to hear from pharma R&D and patient advocacy on how patient involvement gets done to drive greater efficiencies and inclusivity in clinical research with better outcomes.

“Patients as Partners Europe brings advocates and sponsors together in a unique forum focused on improving collaborations that result in meaningful impact for patients,” said 2024 co-chair, Victoria DiBiaso, MPH, Global Head, Patient Informed Development & Health Value Translation, Sanofi.

The 2024 keynotes and featured speakers include:

• Patient Advocate Keynote Derek Stewart, OBE on understanding mental health support in clinical research
• Patient Advocate Keynote Sarah Zenner Dolan, a former biotech executive on navigating clinical trials as a patient
• GSK’s Andrew Garvey, Global Patient Advocacy Lead, on what has been working, and what has not, in GSK’s effort to advance patient engagement in clinical trials
• Pfizer’s Patrick Gallogly, Medical Advisor, Pfizer, on the learnings generated from an industry-first LGBTQ+ oncology advisory board
• Lundbeck’s Anders Lassen, Senior Director, Patient Insights, on using patient-centric integrated evidence approaches to inform drug development decisions
• Boehringer Ingelheim’s Annie Gilbert, Global Patient Advocacy Lead, on the pilot program bridging the communication gap by sending trial updates to patients
• Ipsen’s Oleksandr Gorbenko,​​​​​​​ Global Patient Affairs Director, Neurosciences, on how Ipsen partnered with patient advocacy to create robust patient experience mapping
• AstraZeneca’s Lisa Kerr, Senior Director, R&D Patient Science, on creating a measurement strategy and business investment case to scale patient-centric R&D approaches
• Astellas’ Stephen Head, Senior Director, Patient Partnerships, on instilling conscious awareness of the patient into everyday work practices
• Prostate Cancer Research’s David James, Director of Patient Projects, on demystifying and diversifying clinical trials to engage underserved communities

“Patients as Partners® Europe presents case examples on how patient involvement in clinical research can accelerate medicine development, how it can improve better access, inclusivity and diversity,” said Valerie Bowling, Executive Director.

Key topics to be addressed include:

• ​​​​The future of patient-informed research
• Understanding patient preferences in decentralized clinical trials
• Advancing health equity and diversifying clinical trials to engage underserved communities
• The patient experience data landscape and returning patient data
• Turning patient insights into action
• Mapping and measuring patient engagement
• Patient burden-reducing solutions and technologies
• Regulatory requirements and patient engagement in drug development

The 2024 meeting is co-chaired by ​​​​​​​Sanofi’s Victoria DiBiaso, MPH, Global Head, Patient Informed Development & Health Value Translation; Patient Advocate, ​​​​​​​​​​​​​​Alfred Samuels; and Parexel’s Rosamund Round, VP, Patient Engagement.

About Patients as Partners® Europe:
Patients as Partners® Europe is co-produced with patients, industry, academia, government and nonprofit organizations to establish a well-rounded program that addresses the needs of all stakeholders seeking to implement and advance patient involvement, access and diversity across the entire clinical development continuum. To learn more about Patients as Partners and access the full agenda, visit PatientsAsPartnersEU.com.

About the Conference Forum:
The Conference Forum is a life science industry research, conference development and marketing firm. The company brings the full spectrum of executives together to share ideas and information on how to advance efficient medicine development and delivery, patient diversity and access. They produce trusted conferences, webinars, podcasts, digital editorial and provide marketing services. To learn more, visit theconferenceforum.org.

Media contact:

Patients as Partners® Europe
service@tcfllc.org
(646) 290-8449
https://patientsaspartnerseu.com/

Website:

SOURCE: Patients as Partners® Europe